A specialty pharma company focused on hospital/acute care settings, developing non-opioid products for acute pain and neuromuscular blockers and related compounds for rapid induction and reversal of neuromuscular blockade. Our products include meloxicam IV, a proprietary long-acting treatment for moderate to severe pain and a proprietary intranasal form of dexmedetomidine for peri-procedural pain